Tekmira Pharmaceuticals said this week that it has priced a public offering of 3.75 million shares of its common stock at $8 a share, for gross proceeds of $30 million.
Tekmira stock closed at $8.82 on Wednesday.
The company said that the underwriters of the offering have also been granted an option to purchase an additional 562,500 shares.
The offering is expected to close on or about Oct. 22.